Cerebral Protection System Market: By Products (Clarets Sentinel System, Keystone Hearts Triguard Device, and Embrella Embolic Deflector), By Application (Cardiovascular Disease and Peripheral Disease), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Cerebral Protection System Market size was valued at USD 726.5 million in 2022 and is poised to grow at a significant CAGR of 9.2% over 2023-2029. The main treatment option for severe aortic stenosis that cannot be operated on or presents a high surgical risk is transcatheter aortic valve implantation (TAVI). According to diffusion-weighted MRI research, certain silent brain infarcts develop following TAVI and cause subsequent mental decline. During TAVI, embolic protection devices provide a mechanical barrier against the debris that can induce brain embolization. The risk of cerebrovascular events associated with TAVI has decreased because of these devices. The market is growing due to an increase in the geriatric population, adoption of cutting-edge surgical procedures, and investments in health care. Technological development in embolic protection devices will contribute to corporate growth in a beneficial way. Technological developments that resulted in the creation of enhanced embolic protection devices for TAVI like CLEAN-TAVI offer a variety of prospects for the market's expansion. The market will grow if companies concentrate on creating new and cost-effective technologies, for instance, the double-occlusion balloon system in Medtronic's Mo. Ma Ultra proximal cerebral protection device ensures proximal embolic protection before crossing a carotid lesion. The market for cerebral protection devices will expand due to the development of these products. Furthermore, favorable reimbursement policies for these systems will boost business growth by increasing usage.

Cerebral Protection System Market Key Developments:

In March 2020, The TriGUARD 3 TM Cerebral Embolic Protection (CEP) Device received European CE Mark from Keystone Heart Ltd., a Venus MedTech Company. During Transcatheter Aortic Valve Implantation (TAVI) and other transcatheter cardiac procedures, the device is meant to divert embolic material away from cerebral circulation, reducing the risk of brain injury. The TriGUARD 3TM Cerebral Embolic Protection Device was used for the first time in a commercial case in the world, according to Keystone Heart, a Venus MedTech company. For $300 million, Venus MedTech (Hangzhou) Inc. bought a 100 percent stock interest and corresponding equity in Cardio valve Ltd. Cardio valve, established in Yehuda, Israel, makes the Cardio valve system, which is a transcatheter interventional replacement solution for mitral or tricuspid regurgitation.

Cerebral Protection System Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.2%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Cerebral Protection System Market Dynamics

Global cerebral thrombotic protection devices are used to protect the brain before, during, and after TAVI in hospitals (TAVR). The gadget inflates a balloon in the left atrium or inside the heart. Using global cerebral embolic protection devices for TAVI at home aims to reduce the risk of heart attack and stroke, enabling patients to avoid going to the hospital and instead stay at home. However, the market's expansion is anticipated to be hampered by the high cost of devices & systems and a strict regulatory environment might limit the development of the embolic protection devices market.

Cerebral Protection System Market Segmentation

By Type
  • Clarets Sentinel System
  • Keystone Hearts Triguard Device
  • Embrella Embolic Deflector
By Application
  • Cardiovascular Disease
  • Peripheral Disease
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The cerebral protection system market is projected to expand at a CAGR of 9.2% during the forecast period

Praxair Inc., AMCS Corporation, The Linde Group, Iwatani Corporation, Messer Group GmbH

North America is the fastest-growing region for cerebral protection system market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Cerebral Protection System Market Introduction 
2.1.Global Cerebral Protection System Market  - Taxonomy
2.2.Global Cerebral Protection System Market  - Definitions
2.2.1. By Type 
2.2.2. By Application
2.2.3. By Region
3.Global Cerebral Protection System Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cerebral Protection System Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cerebral Protection System Market  By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Clarets Sentinel System
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Keystone Hearts Triguard Device
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Embrella Embolic Deflector
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Cerebral Protection System Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cardiovascular Disease
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Peripheral Disease
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Cerebral Protection System Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Cerebral Protection System Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Clarets Sentinel System
8.1.2.Keystone Hearts Triguard Device
8.1.3.Embrella Embolic Deflector
8.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Cardiovascular Disease
8.2.2.Peripheral Disease
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Cerebral Protection System Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Clarets Sentinel System
9.1.2.Keystone Hearts Triguard Device
9.1.3.Embrella Embolic Deflector
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cardiovascular Disease
9.2.2.Peripheral Disease
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Cerebral Protection System Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Clarets Sentinel System
10.1.2.Keystone Hearts Triguard Device
10.1.3.Embrella Embolic Deflector
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cardiovascular Disease
10.2.2.Peripheral Disease
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Cerebral Protection System Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Clarets Sentinel System
11.1.2.Keystone Hearts Triguard Device
11.1.3.Embrella Embolic Deflector
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cardiovascular Disease
11.2.2.Peripheral Disease
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Cerebral Protection System Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Clarets Sentinel System
12.1.2.Keystone Hearts Triguard Device
12.1.3.Embrella Embolic Deflector
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cardiovascular Disease
12.2.2.Peripheral Disease
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Keystone Heart
13.2.2.Claret Medical, Inc.
13.2.3.Edwards Lifesciences Corporation
13.2.4.Abbott Laboratories
13.2.5.Allium Medica
13.2.6.Boston Scientific
13.2.7.Cardinal Health
13.2.8.Contego Medical
13.2.9.Gore Medical
13.2.10.Medtronic
14. Research Methodology 
15. Appendix and Abbreviations 
  • Keystone Heart
  • Claret Medical, Inc.
  • Edwards Lifesciences Corporation
  • Abbott Laboratories
  • Allium Medica
  • Boston Scientific
  • Cardinal Health
  • Contego Medical
  • Gore Medical
  • Medtronic

Adjacent Markets